Evidence map›Paper›PMID 40606957›Full record

ArticleHealth psychology and behavioral medicine2025

Somatosensory amplification and psychological distress in cancer survivors: the mediating role of fear of cancer recurrence.

Shahaf Bitan, Shimrit Daches, Ilanit Hasson-Ohayon

Abstract read
In one paragraph

Article in Health psychology and behavioral medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Somatosensory amplification and fear of cancer recurrence: Moderating effects of emotion regulation difficulties.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shahaf BitanDepartment of Psychology, Bar-Ilan University, Ramat-Gan, Israel.ORCID https://orcid.org/0009-0009-2687-8755
Shimrit DachesDepartment of Psychology, Bar-Ilan University, Ramat-Gan, Israel.
Ilanit Hasson-OhayonDepartment of Psychology, Bar-Ilan University, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Somatosensory amplification (SSA) refers to the tendency to experience body sensations as intense, noxious, and disturbing, and is associated with higher levels of anxiety and depression among cancer survivors. Body sensations among survivors are highly attributed to the possibility of cancer recurrence, thus triggering fear of cancer recurrence (FCR). Given that FCR itself is correlated with higher psychological distress, in this study we examined the mediating role of FCR in the relationship between SSA and symptoms of anxiety and depression among cancer survivors. Materials and Methods: One hundred and seventeen cancer survivors up to 10 years post-diagnosis took part in this cross-sectional study. Measures consisted of a demographic and medical questionnaire; the anxiety and depression domains of the Patient Reported Outcomes Measurement Information System (PROMIS); the Somatosensory Amplification Scale; and the Fear of Cancer Recurrence Inventory-Short Form. Mediation analyses were conducted to determine whether FCR mediated the relationships between SSA and both anxiety and depression. Results: SSA was found to be positively correlated with anxiety, depression, and FCR, and FCR was found to be positively correlated with anxiety and depression. FCR was found to fully mediate the relationships between SSA and both anxiety and depression. Conclusion: The findings suggest that FCR may serve as a mechanism linking SSA to psychological distress, highlighting the need to consider targeting FCR in interventions for cancer survivors.

Indexed as

Anxietycancer survivorsdepressionfear of cancer recurrencesomatosensory amplification

Identifiers

PMID40606957
PMCPMC12217098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.